These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19364699)

  • 1. Editorial: What have we lost in the wake of the rosiglitazone controversy?
    Zarich SW; Nesto RW
    Endocr Pract; 2009 Apr; 15(3):273-4. PubMed ID: 19364699
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice effect of rosiglitazone discontinuation on glycemic control.
    Fanning EL; Weissman PN; Menditto LA
    Endocr Pract; 2009 Apr; 15(3):270-2. PubMed ID: 19364698
    [No Abstract]   [Full Text] [Related]  

  • 3. In brief: rosiglitazone (Avandia) unbound.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):12. PubMed ID: 24662977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Doubts as to the cardiovascular safety of rosiglitazone].
    Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2236-7; author reply 2237. PubMed ID: 17969577
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of rosiglitazone in the treatment of type 2 diabetes.
    Singh S; Loke YK
    Expert Opin Drug Saf; 2008 Sep; 7(5):579-85. PubMed ID: 18759710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone and cardiovascular disease: an epidemiologist's perspective.
    McGuire DK
    Diab Vasc Dis Res; 2007 Jun; 4(2):77-9. PubMed ID: 17654438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect].
    Erdmann E; Scherbaum WA
    MMW Fortschr Med; 2007 Dec; 149(49-50):49-50. PubMed ID: 18236983
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosiglitazone and heart failure: the controversy and clinical implications.
    Virk IS; Ruby RS; Tepper D
    Congest Heart Fail; 2007; 13(5):293-5. PubMed ID: 17917497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 10. Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.
    Mitka M
    JAMA; 2013 Jul; 310(3):246-7. PubMed ID: 23860970
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular safety of rosiglitazone.
    Krall RL
    Lancet; 2007 Jun; 369(9578):1995-1996. PubMed ID: 17574083
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
    Odom J; Williamson B; Carter L
    Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Doubts as to the cardiovascular safety of rosiglitazone].
    Hoekstra JB; Bossuyt PM; de Vries JH
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1449-50. PubMed ID: 17633972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone: seeking a balanced perspective.
    The Lancet
    Lancet; 2007 Jun; 369(9576):1834. PubMed ID: 17544746
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes drug safety update: Avandia and your heart.
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
    [No Abstract]   [Full Text] [Related]  

  • 17. Pioglitazone is a valid alternative to rosiglitazone.
    Derosa G
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
    Stockl KM; Le L; Zhang S; Harada AS
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new rosiglitazone story: its place today in type 2 diabetes management.
    Ambery P; Pandya B
    Prim Care Diabetes; 2009 Feb; 3(1):57-9. PubMed ID: 19269912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007.
    Boyle P
    South Med J; 2007 Nov; 100(11):1063-4. PubMed ID: 17984728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.